NASDAQ:AUTL

Autolus Therapeutics Earning Date

USA |NASDAQ |USD |ADR

AUTL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.51 $-0.47 $-0.72
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $250.00K $1.51M $680.00K

Autolus Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

AUTL Earnings Date & History Chart

AUTL Earnings & Revenue Forecast

AUTL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.51 $-0.58 $-0.44
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-1.95 $-2.15 $-1.39
Dec 2022 10 $-1.90 $-2.33 $-0.92

AUTL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.51 $-0.51 $-0.51
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.95 $-1.99 $-1.99
Dec 2022 0 / 0 $-1.92 $-1.92 $-1.92

AUTL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $250.00K $0.00 $640.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $2.04M $0.00 $3.20M
Dec 2022 10 $760.00K $0.00 $1.77M

AUTL Earnings Date & Revenue History

AUTL Earnings History

|
Show More
Show More

AUTL Revenue History

|
Show More
Show More

Autolus Therapeutics Next Earnings Date & Report

AUTL Next Earnings Date & Report Preview: Sep 2021 (FQ)

AUTL's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 9 analysts, the average EPS estimation for Autolus Therapeutics's next quarterly earnings is $-0.51, with a low EPS estimation of $-0.56, and a high estimation of $-0.45.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.51, the last 2 month trend is $-0.51, and the 3 month trend is $-0.51.

Based on 9 analysts, the average revenue estimation is $250.00K, with a low revenue estimation of $0.00, and a high estimation of $640.00K.

Autolus Therapeutics Previous Earnings Dates & Reports

AUTL Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Autolus Therapeutics's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

AUTL's earnings per share (EPS) was $-0.47, beating the consensus analysts forecast of $-0.49 by 4.26%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -11.32%, and higher than the same period a year before (Jun 2020) by -24.19%.

Revenues were $1.51M, worse than the forecast of $1.65M by -8.39%, up by 460.22% from the previous quarter , and up by 414.33% from the same period last year.

The company reported a net income of $-33.17M.

Free cash flow for the quarter was $-38.12M , compared to $-39.24M last quarter and $-29.46M a year before.

AUTL ended the quarter with $22.68M in total debt, a decrease of -2.39% compared to the previous quarter, and a decrease of -19.62% compared to the same quarter a year before.

AUTL Previous Earnings Date & Report Recap: Sep 2020 (FY)

Autolus Therapeutics's previous annual earnings date was Nov 5, 2020 for its fiscal year ended Sep 30, 2020.

AUTL's earnings per share (EPS) was $-2.78.

Revenues were $242.00K, down by -91.68% from previous year's revenue.

The company reported a net income of $-142.09M.

Autolus Therapeutics reported a free cash flow of $-132.44M for its fiscal year, compared to $-120.15M a year ago.

The company ended the fiscal year with $54.16M in total debt, an increase of 106.56% compared to the previous year.